Skip to content

Exercise and the Menstrual Cycle in Type 1 Diabetes

Type 1 Diabetes

Female participants with type 1 diabetes using oral contraceptives will be asked to wear a continuous glucose monitor for at least three days on two separate occasions (once during the last week of active pills and once during the no pill/placebo pill phase of the menstrual cycle). An exercise session (45 minutes of aerobic exercise at 60% VO2peak on a cycle ergometer) will take place at 5 pm on the second day of glucose monitoring.

null

Conditions de participation

  • Sexe:

    FEMALE

  • Âges admissibles:

    18 to 50

Critères de participation

Inclusion Criteria:

* type 1 diabetes diagnosed for at least 1 year
* regular menses
* using monophasic oral contraceptives
* residing in Edmonton, Alberta and able to visit the lab at the University of Alberta

Exclusion Criteria:

* HbA1c \> 9.9%
* frequent and unpredictable hypoglycemia
* change in insulin management strategy within two months of the study
* use of an automated insulin delivery system
* blood pressure \> 140/95
* history of cardiovascular disease
* severe peripheral neuropathy
* active proliferative retinopathy
* use of medications (other than insulin) that would affect blood glucose levels
* any musculoskeletal condition that would contraindicate exercise (e.g. sprain, strain, joint injury, etc.)

Lieu de l'étude

Alberta Diabetes Institute
Alberta Diabetes Institute
Edmonton, Alberta
Canada

Contactez l'équipe d'étude

Primary Contact

Jane E Yardley, PhD

[email protected]
7806791688
Étude parrainée par
University of Alberta
Participants recherchés
Plus d'informations
ID de l'étude: NCT05188014